Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 400

1.

Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.

Millay DP, Maillet M, Roche JA, Sargent MA, McNally EM, Bloch RJ, Molkentin JD.

Am J Pathol. 2009 Nov;175(5):1817-23. doi: 10.2353/ajpath.2009.090107. Epub 2009 Oct 15.

2.

Defective membrane repair in dysferlin-deficient muscular dystrophy.

Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, McNeil PL, Campbell KP.

Nature. 2003 May 8;423(6936):168-72.

PMID:
12736685
3.

Dysferlin and the plasma membrane repair in muscular dystrophy.

Bansal D, Campbell KP.

Trends Cell Biol. 2004 Apr;14(4):206-13. Review.

PMID:
15066638
4.

Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity.

Demonbreun AR, Rossi AE, Alvarez MG, Swanson KE, Deveaux HK, Earley JU, Hadhazy M, Vohra R, Walter GA, Pytel P, McNally EM.

Am J Pathol. 2014 Jan;184(1):248-59. doi: 10.1016/j.ajpath.2013.09.009. Epub 2013 Oct 29.

5.

Dysferlin protein analysis in limb-girdle muscular dystrophies.

Vainzof M, Anderson LV, McNally EM, Davis DB, Faulkner G, Valle G, Moreira ES, Pavanello RC, Passos-Bueno MR, Zatz M.

J Mol Neurosci. 2001 Aug;17(1):71-80.

PMID:
11665864
6.

Animal models for genetic neuromuscular diseases.

Vainzof M, Ayub-Guerrieri D, Onofre PC, Martins PC, Lopes VF, Zilberztajn D, Maia LS, Sell K, Yamamoto LU.

J Mol Neurosci. 2008 Mar;34(3):241-8. doi: 10.1007/s12031-007-9023-9. Epub 2008 Jan 18. Review.

PMID:
18202836
7.

Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.

Flix B, de la Torre C, Castillo J, Casal C, Illa I, Gallardo E.

Int J Biochem Cell Biol. 2013 Aug;45(8):1927-38. doi: 10.1016/j.biocel.2013.06.007. Epub 2013 Jun 19.

PMID:
23792176
8.

Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.

Ho M, Post CM, Donahue LR, Lidov HG, Bronson RT, Goolsby H, Watkins SC, Cox GA, Brown RH Jr.

Hum Mol Genet. 2004 Sep 15;13(18):1999-2010. Epub 2004 Jul 14.

PMID:
15254015
9.

Characterisation of the dysferlin skeletal muscle promoter.

Foxton RM, Laval SH, Bushby KM.

Eur J Hum Genet. 2004 Feb;12(2):127-31.

10.

Pathological analysis of muscle hypertrophy and degeneration in muscular dystrophy in gamma-sarcoglycan-deficient mice.

Sasaoka T, Imamura M, Araishi K, Noguchi S, Mizuno Y, Takagoshi N, Hama H, Wakabayashi-Takai E, Yoshimoto-Matsuda Y, Nonaka I, Kaneko K, Yoshida M, Ozawa E.

Neuromuscul Disord. 2003 Mar;13(3):193-206.

PMID:
12609501
11.

Absence of dysferlin alters myogenin expression and delays human muscle differentiation "in vitro".

de Luna N, Gallardo E, Soriano M, Dominguez-Perles R, de la Torre C, Rojas-García R, García-Verdugo JM, Illa I.

J Biol Chem. 2006 Jun 23;281(25):17092-8. Epub 2006 Apr 11.

12.

Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle.

Klinge L, Harris J, Sewry C, Charlton R, Anderson L, Laval S, Chiu YH, Hornsey M, Straub V, Barresi R, Lochmüller H, Bushby K.

Muscle Nerve. 2010 Feb;41(2):166-73. doi: 10.1002/mus.21166.

PMID:
20082313
13.
14.

[Amyloidosis in muscular dystrophy].

Carl M, Röcken C, Spuler S.

Pathologe. 2009 May;30(3):235-9. doi: 10.1007/s00292-009-1129-0. German.

PMID:
19326120
15.

Sarcoglycans in muscular dystrophy.

Hack AA, Groh ME, McNally EM.

Microsc Res Tech. 2000 Feb 1-15;48(3-4):167-80. Review.

PMID:
10679964
16.

Common pathological mechanisms in mouse models for muscular dystrophies.

Turk R, Sterrenburg E, van der Wees CG, de Meijer EJ, de Menezes RX, Groh S, Campbell KP, Noguchi S, van Ommen GJ, den Dunnen JT, 't Hoen PA.

FASEB J. 2006 Jan;20(1):127-9. Epub 2005 Nov 23.

PMID:
16306063
17.

Expression of gamma -sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex.

Barresi R, Moore SA, Stolle CA, Mendell JR, Campbell KP.

J Biol Chem. 2000 Dec 8;275(49):38554-60.

18.

Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice.

Leriche-Guérin K, Anderson LV, Wrogemann K, Roy B, Goulet M, Tremblay JP.

Neuromuscul Disord. 2002 Feb;12(2):167-73.

PMID:
11738359
19.

[Dysferlin expression in limb-girdle muscular dystrophy and Miyoshi myopathy: analysis of 45 cases].

Ren SC, Yan CZ, Li MX, Liu SP, Wu JL, Zhao YY, Li W, Li DN.

Zhonghua Yi Xue Za Zhi. 2007 Jun 5;87(21):1486-90. Chinese.

PMID:
17785089
20.

Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.

Wenzel K, Carl M, Perrot A, Zabojszcza J, Assadi M, Ebeling M, Geier C, Robinson PN, Kress W, Osterziel KJ, Spuler S.

Hum Mutat. 2006 Jun;27(6):599-600.

PMID:
16705711

Supplemental Content

Support Center